Cargando…

KSHV miRNAs Decrease Expression of Lytic Genes in Latently Infected PEL and Endothelial Cells by Targeting Host Transcription Factors

Kaposi’s sarcoma-associated herpesvirus (KSHV) microRNAs are encoded in the latency-associated region. Knockdown of KSHV miR-K12-3 and miR-K12-11 increased expression of lytic genes in BC-3 cells, and increased virus production from latently infected BCBL-1 cells. Furthermore, iSLK cells infected wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plaisance-Bonstaff, Karlie, Choi, Hong Seok, Beals, Tyler, Krueger, Brian J., Boss, Isaac W., Gay, Lauren A., Haecker, Irina, Hu, Jianhong, Renne, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213575/ https://www.ncbi.nlm.nih.gov/pubmed/25341664 http://dx.doi.org/10.3390/v6104005

Ejemplares similares

A Toolbox for Herpesvirus miRNA Research: Construction of a Complete Set of KSHV miRNA Deletion Mutants
por: Jain, Vaibhav, et al.
Publicado: (2016)

Comprehensive analysis of the KSHV MiRNA targetome by Ago-HITS-CLIP
por: Haecker, Irina, et al.
Publicado: (2012)

The activation of KSHV lytic cycle blocks autophagy in PEL cells
por: Granato, Marisa, et al.
Publicado: (2015)

A core laboratory for the generation of quality-controlled g-herpesvirus bacmids: generation of KSHV microRNA mutants
por: Krueger, Brian, et al.
Publicado: (2012)

Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis
por: Barrett, Lindsey, et al.
Publicado: (2020)

Sphingosine Kinase-2 Maintains Viral Latency and Survival for KSHV-Infected Endothelial Cells
por: Dai, Lu, et al.
Publicado: (2014)

Epigenetic Analysis of KSHV Latent and Lytic Genomes
por: Toth, Zsolt, et al.
Publicado: (2010)

Echinomycin as a promising therapeutic agent against KSHV-related malignancies
por: Chen, Jungang, et al.
Publicado: (2023)

Upregulation of xCT by KSHV-Encoded microRNAs Facilitates KSHV Dissemination and Persistence in an Environment of Oxidative Stress
por: Qin, Zhiqiang, et al.
Publicado: (2010)

SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
por: Chen, Jungang, et al.
Publicado: (2021)

The landscape of transcription initiation across latent and lytic KSHV genomes
por: Ye, Xiang, et al.
Publicado: (2019)

Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1
por: Granato, Marisa, et al.
Publicado: (2018)

Ago HITS-CLIP Expands Understanding of Kaposi's Sarcoma-associated Herpesvirus miRNA Function in Primary Effusion Lymphomas
por: Haecker, Irina, et al.
Publicado: (2012)

Correction: Ago HITS-CLIP Expands Understanding of Kaposi's Sarcoma-associated Herpesvirus miRNA Function in Primary Effusion Lymphomas
por: Haecker, Irina, et al.
Publicado: (2013)

Systematic Analysis of a Xenograft Mice Model for KSHV(+) Primary Effusion Lymphoma (PEL)
por: Dai, Lu, et al.
Publicado: (2014)

Coordination of KSHV Latent and Lytic Gene Control by CTCF-Cohesin Mediated Chromosome Conformation
por: Kang, Hyojeung, et al.
Publicado: (2011)

A Viral Genome Landscape of RNA Polyadenylation from KSHV Latent to Lytic Infection
por: Majerciak, Vladimir, et al.
Publicado: (2013)

Molecular Biology of KSHV Lytic Reactivation
por: Purushothaman, Pravinkumar, et al.
Publicado: (2015)

Regulation of KSHV Latency and Lytic Reactivation
por: Broussard, Grant, et al.
Publicado: (2020)

A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells
por: Yang, Yajie, et al.
Publicado: (2014)

RSK-c-Fos in KSHV lytic progression
por: Li, Xiaojuan, et al.
Publicado: (2015)

Contribution of the KSHV and EBV lytic cycles to tumourigenesis
por: Manners, Oliver, et al.
Publicado: (2018)

Inhibition of Tip60 Reduces Lytic and Latent Gene Expression of Kaposi’s Sarcoma-Associated Herpes Virus (KSHV) and Proliferation of KSHV-Infected Tumor Cells
por: Simpson, Sydney, et al.
Publicado: (2018)

RSK1 SUMOylation is required for KSHV lytic replication
por: Liu, Zhenshan, et al.
Publicado: (2021)

microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus
por: Sethuraman, Sunantha, et al.
Publicado: (2017)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Classic KSHV/HHV-8-positive Primary Effusion Lymphoma (PEL): A Systematic Review and Meta-Analysis of Case Reports
por: Cozzi, Ilaria, et al.
Publicado: (2022)

KSHV encoded miRNA single nucleotide polymorphisms identified in clinical samples can affect miRNA processing and level of expression
por: Marshall, Vickie, et al.
Publicado: (2012)

Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
por: Velasco, P, et al.
Publicado: (2009)

Activation of DNA Damage Response Pathways during Lytic Replication of KSHV
por: Hollingworth, Robert, et al.
Publicado: (2015)

KSHV Reactivation and Novel Implications of Protein Isomerization on Lytic Switch Control
por: Guito, Jonathan, et al.
Publicado: (2015)

Efficient lytic induction of kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines
por: Kang, Hyunju, et al.
Publicado: (2014)

Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus
por: Chen, Jungang, et al.
Publicado: (2022)

Role of Histamine and Related Signaling in Kaposi’s Sarcoma-Associated Herpesvirus Pathogenesis and Oncogenesis
por: Chen, Jungang, et al.
Publicado: (2023)

Latently KSHV-Infected Cells Promote Further Establishment of Latency upon Superinfection with KSHV
por: Gam ze Letova, Chen, et al.
Publicado: (2021)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

C/EBPbeta mediates bortezomib-induced EBV and KSHV lytic gene expression
por: O’Farrell, Courtney, et al.
Publicado: (2010)

Cell Type-Specific Interferon-γ-mediated Antagonism of KSHV Lytic Replication
por: Park, Mi-Kyung, et al.
Publicado: (2019)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV
por: Naik, Nenavath Gopal, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lek6si6e0prta8n2urq7mgdimh